Association of Tumor Necrosis Factor-α (-G308A) Polymorphism with risk of Upper Gastrointestinal Bleeding from Schistosomiasis in Pernambuco

ABSTRACT

Background:

We evaluated the association between polymorphisms in the tumor necrosis factor alpha (TNF-α) (-G308A) gene and upper gastrointestinal bleeding (UGIB) in schistosomiasis.

Methods:

This was a transverse study involving 294 Brazilian patients infected with Schistosoma mansoni.

Results:

The homozygous A/A genotype in TNF-α (-G308A) showed a risk association (prevalence ratio = 1.90, p = 0.008) with UGIB. There was no statistically significant difference in serum TNF-α levels between the clinical groups.

Conclusions:

The polymorphic TNF-α (-G308A) can be a risk factor for UGIB, in addition to being a potentially predictive factor for the severity of UGIB in schistosomiasis.

Keywords:
Schistosoma mansoni; Tumor necrosis factor alpha; Genetic polymorphism; Gastrointestinal hemorrhage

Schistosomiasis is a chronic parasitic infection that affects approximately 240 million people worldwide¹. In Brazil, approximately 1.5 million people are presently infected by the hemoparasite Schistosoma mansoni (S. mansoni), especially in the Northeast region² and mainly in the state of Pernambuco, which contains the highest number of deaths from this disease in the country³.

The pathological process of the disease occurs through an immune response to the parasite eggs deposited in the liver, causing a granulomatous inflammatory reaction^1,3. This process causes periportal fibrosis (PPF), which leads to portal vein obstruction, followed by increased portal hypertension and the appearance of esophageal varices, which can rupture and cause upper gastrointestinal bleeding (UGIB)^1,2,4.

UGIB is a serious complication of the disease, especially in the advanced hepatosplenic form⁴. The probability of esophageal vessel rupture in schistosomiasis patients is 11-30%⁵, whereas the mortality caused by this complication is 10-20%⁶. Tumor necrosis factor-alpha (TNF-α) is an inflammatory cytokine that functions in the liver's regenerative process, forming hepatic granulomas and activating myofibroblasts⁷. This cytokine promotes the production of serum proteins by liver cells, such as fibrinogen and C-reactive protein, which causes an acute inflammatory reaction⁶.

The TNF-α gene is located in the human leukocyte antigen class III on chromosome 6p21.3^1.6. Single nucleotide polymorphisms (SNP) are common in the promoter region of the TNF-α gene and may influence the function or expression of this protein^1,6. Among these variations, one can find (-G308A) (rs1800629), in which there is a substitution of guanine (G) by adenine (A), creating two alleles (G, A) and three genotypes (AA, GG, and GA). In comparison with allele G, allele A is associated with increased levels of the TNF-α constituent^1,6.

The association found between the polymorphisms and the increased level of the TNF-α constituent is a possible explanation of the evolutionary process of PPF¹. When compared to genotype GG, genotype GA/AA represented a protective factor for regression of the pattern and degree of PPF¹. Thus, it has been suggested that the TNF-α (-G308A) (rs1800629) polymorphism may be a prognostic factor for schistosomiatic PPF¹. The impact of the expression of polymorphic variations in TNF-α and its effect on the severity of UGIB in patients with schistosomiasis needs to be better elucidated.

This study analyzed the association between TNF-α (-G308A) (rs1800629) and UGIB in S. mansoni endemic populations in the state of Pernambuco, Northeast Brazil.

This cross-sectional study was carried out from August 2020 to May 2021, with 294 individuals infected with S. mansoni, which determined the TNF-α (-G308A) polymorphism and serum concentrations. Diagnosis of the clinical forms of the disease was determined by the medical reports and physical examination of the patients, in addition to the evaluation of upper abdominal ultrasound to confirm the diagnosis and exclude other liver diseases. This ultrasound evaluation was performed only by the endoscopy operator of the Hospital das Clínicas/ Universidade Federal de Pernambuco (HC-UFPE) Unit, using equipment (Siemens Acuson S2000), with a convex transducer of 3.5-5.0 Mhz. To define the PPF pattern, the Niamey⁷ classification was used: A, no fibrosis; B, suspected fibrosis; C, light; D, moderate; E, advanced; and F, very advanced. Patients were also evaluated using upper digestive endoscopy to diagnose or exclude esophageal varices.

These individuals were divided into two groups: Group 1 contained 108 individuals with the hepatosplenic (HE) form, advanced PPF (Pattern E or F), and Group 2 contained 186 individuals with the hepatointestinal (HI) form, with mild PPF (Pattern C) or without fibrosis (Pattern A), without UGIB. All participants were over 18 years of age and were treated at the Gastroenterology Clinic of the Hospital das Clínicas of the Federal University of Pernambuco (HC-UFPE), Recife, Brazil.

Patients with a history of other hepatic comorbidities, such as hepatitis B and C (examination performed through serology of antigens and antibodies), cirrhosis, hepatic steatosis, and PPF Pattern D (Niamey's classification) were evaluated using ultrasound, as other clinical forms of schistosomiasis were excluded.

To determine GG, GA, and AA genotypes, biological samples were collected (blood) and the DNA was subjected to the polymerase chain technique for restriction fragment polymorphism analysis (PCR-RFLP), being isolated with the Ncol enzyme for single nucleotide polymorphism (SNP) detection in the promoter region TNF-α (rs1800629). In this region, the substitution of the nitrogenous base guanine (G) by adenine (A) occurs at position -308 of gene¹.

An immunoenzymatic assay was performed using a commercial ELISA kit (Biosource, Invitrogen Corporation, Carlsbad, CA, USA) following the manufacturer's instructions to measure the serum levels of TNF-α. Results are expressed in pg/mL, based on standard curves (sensitivity <1.7 pg/mL). The median cut-off point was the median 32pg/mL and 148 individuals were evaluated at this stage.

Crude prevalence ratio (PR) and 95% confidence intervals (95% CI) were estimated. The association between the TNF-α (-G308A) polymorphism and UGIB was evaluated with Fisher’s exact test or Chi-square test at a significance level of 0.05. Epi-Info software version 3.5.5 (CDC, Atlanta, GA, USA) was used, and the result was considered significant when p< 0.05.

This study was approved by the Ethics and Research Committee of the Center for Health Sciences, UFPE, under protocols 113.199 and 03161512.6.0000.5208.

The mean age of the participants was 48 years (standard deviation, 14 years). There was no statistically significant difference in the sex distribution (p= 0.192). There was no evidence of an association between serum TNF-α levels and the clinical groups (PR=1.472, 95% CI=0.8199 - 2.6428, p=0.2221) (Table 1).

TABLE 1:
Analysis of the median serum levels of TNF-α in patients with schistosomiasis between the clinical groups, Pernambuco, Brazil.

TNF-α and UGIB by Dosage
	Yes (n=72)		No (n=76)
Characteristics	N	%	N	%	PR	95% CI	p-value
Dosage TNF-α*
<32 pg/mL	64	89	61	80	1.472	[0.8199 - 2.6428]	0.2221
>32 pg/mL	8	11	15	20
Total	72	100	76	100

• *148 patients were evaluated for serum TNF-α dosage; TNF-α: tumor necrosis factor-alpha; UGIB: upper gastrointestinal bleeding; PR: prevalence ratio; CI: confidence interval.

Genotype AA showed a risk association (PR=1.90, 95% CI=1.322-2.757, p=0.008) for UGIB, when compared with genotypes GG and GA (Table 2).

TABLE 2:
Bivariate analysis of associations between polymorphic TNF-α (-G308A) and UGIB, in patients with schistosomiasis in the state of Pernambuco, Brazil.

	Genotypes for TNF-α -308 and UGIB
	Yes (n=108)		No (n=186)
Genotypes	n	%	n	%	PR	95% CI	p-value
TNF-α (-308)
GG	55	51	106	57		(Reference)
GA	38	35	72	39	1.01	[0.723 - 1.413]	1
AA	15	14	8	4	1.90	[1.322 - 2.757]	0.008
Total	108	100	186	100

• TNF-α: tumor necrosis fator-alpha, UGIB: Upper gastrointestinal bleeding; PR: prevalence ratio; CI: confidence interval.

This study investigated the impact of the TNF-α (-G308A) polymorphism on UGIB. This is the first study to analyze the influence of genetic factors on UGIB in a group of patients with schistosomiasis in the state of Pernambuco, Northeastern Brazil, a region with a high mortality rate in the country⁵.

This study involving Brazilian patients infected with S. mansoni showed that patients with genotype AA had a higher risk of UGIB than those with genotype GG. However, there was no association between serum TNF-α levels in the clinical groups of UGIB.

UGIB is caused by chronic schistosomiasis. UGIB can occur in up to 80% of patients with PPF, with a mortality rate of up to 30% for recurrent episodes. However, not all patients with advanced fibrosis develop esophageal varices, and not all patients with esophageal varices will have UGIB. The frequency of UGIB in Brazil is lower than that in Africa⁸. In addition, mainly in the presence of early grade fibrosis and in young-age patients, the effect on portal hypertension may even precede that on fibrosis and occur in patients with different grades of liver fibrosis⁷. Clinical factors such as esophageal varices and PPF are associated with a higher probability of having two or more cases of UGIB during life^5,9. Opio et al. (2016)⁹ investigated in a cross-sectional study, Opio et al. investigated the profile of upper gastrointestinal bleeding episodes in 107 patients with schistosomiasis from Africa; 94% had severe PPF, and 80% had esophageal varices. A total of 323 occurrences of UGIB were identified throughout the lives of these individuals, with 57% having more than two episodes.

The association between the TNF-α (-G308A) polymorphism and PPF has already been studied¹. Oliveira et al. (2015)¹, through a cohort study, evaluated 124 Brazilians infected with S. mansoni after specific treatment and found a protective association between the genotypes GA/AA and the regression of PPF compared to the genotype GG. There was no association between serum TNF-α levels and the exposed groups; however, it is believed that the TNF-α (-G308A) polymorphism can prevent regression of the pattern and grade of PPF, which is a potential prognostic factor in relation to schistosomiasis PPF.

Silva et al. (2017)⁴ carried out a cross-sectional study of 256 Brazilians with schistosomiasis and different patterns of PPF and found that the AA genotype (-308) was associated with an increased risk of advanced PPF in this population. Serum TNF-α levels were higher in patients with moderate-to-advanced PPF than in those with a mild pattern. Therefore, the AA genotype is considered a risk factor for the severity of advanced PPF in this population.

In humans, although high TNF-α levels are associated with severe hepatic fibrosis^1,4, it is still unclear which cytokines are involved in the progression of schistosomiasis pathology.

Some studies have found no association between this polymorphism and the severity of PPF and hepatic fibrosis^10,11. Moukoko et al. (2003)¹⁰ observed in a Sudanese population that high levels of TNF-α were associated with a higher risk of PPF but found no association between the TNF-α (-G308A) polymorphism and PPF. These authors did not exclude the possibility that this polymorphism influenced the development of PPF.

Kusumoto et al. (2006)¹¹ evaluated 460 hepatitis C vírus (HCV)-positive patients and 63 controls in Japan and found no significant association between this polymorphism and hepatic fibrosis. These authors concluded that these results may have been influenced by ethnic variations and that the TNF-α (-G308A) polymorphism can be associated with hepatic fibrosis.

The influence of this polymorphism on the expression of TNF-α. Some studies have shown that, in comparison with allele G, allele A was associated with increased levels of TNF-α, while others failed to associate the presence of the A allele with different levels of TNF-α production¹². These results may validate the hypothesis of this study, which showed that the tested genotype AA may play an important predictive role for PPF and, consequently, for UGIB in schistosomiasis in the Brazilian population.

In the current study, although there was no difference in serum TNF-α levels between the clinical groups of UGIB, possibly individuals with the genotype AA maintained a residual production of TNF-α after the specific treatment, contributing to less reabsorption of fibrosis and consequently causing complications by UGIB in this group.

The absence of a correlation between TNF-α levels and disease severity, represented by the degree of liver fibrosis, is also shown. There are controversial reports regarding the influence of TNF-α on schistosomiasis pathogenesis. Franco et al. (2021)¹³ evaluated 69 patients with schistosomiasis recruited from an endemic area for schistosomiasis in the north of the State of Sergipe, Brazil. There were no significant correlations between TNF-α levels and advanced degree of fibrosis. Therefore, owing to the small sample size, further studies are necessary to rule out the influence of TNF-α on schistosomiasis pathogenesis.

Another study did not differ between TNF-α levels in obese individuals who underwent bariatric surgery with or without liver fibrosis. The authors reported some limitations to be considered, including a small population of patients, which is mainly due to the high costs of the trials used in this study. In addition, there was no control group, and all individuals evaluated presented some degree of nonalcoholic fatty liver disease, which may limit a better elucidation of the findings and additional extrapolation of these results¹⁴. In addition, the effect of TNF-α on acute liver injury is unclear, and it has been reported that TNF-α plays a dual role in acute liver injury¹⁵.

Considering the limitation of sample size in this study, as well as possible ethnic variations in the population, further studies with larger samples and in other populations are recommended to better analyze these genotypes and their respective doses of TNF-α serum, to better assess whether there is a connection between the TNF-α (-G308A) polymorphism and the expression of TNF-α and UGIB intensity in schistosomiasis.

In conclusion, these results suggest that the TNF-α (-G308A) polymorphism can be a risk factor for UGIB in the Brazilian population, and therefore, can potentially be a predictive factor for the severity of UGIB resulting from PPF in schistosomiasis.

ACKNOWLEDGMENTS

The authors are especially thankful to the patients of the Gastroenterology Clinic of the Hospital das Clínicas/ Universidade Federal de Pernambuco, who accepted to participate, contributing with samples without direct benefit from the results; and to the laboratories of Human Molecular Genetics (University of Pernambuco) and of Virology-Immunology Laboratory Keizo-Asami (LIKA) (Federal University of Pernambuco-UFPE), where the analyses were carried out. This research study was supported by the Federal University of Pernambuco (UFPE), Brazil.

REFERENCES

• ¹
  Oliveira JB, Silva PCV, Vasconcelos LM, Gomes AV, Coêlho MRCD, Cahu GGOM, et al. Influence of Polymorphism (-G308A) TNF-a on the Periportal Fibrosis Regression of Schistosomiasis After Specific Treatment. Genet Test Mol Biomarkers. 2015;19(11):598-603.
• ²
  Brito MIBS, Silva MBA, Quinino LRM. Epidemiological situation and control of schistosomiasis in Pernambuco, Brazil: a descriptive study, 2010-2016. Epidemiol Serv Saude. 2020;29(2):e2019252.
• ³
  Fidelis TAA, Geraldo B-F, Parreiras PM, Coelho PMZ, Araujo N, Chaud MV, et al. Schistosoma mansoni granulomas in the skeletal striated muscles in the murine model of neuroschistosomiasis: histological findings. Mem Inst Oswaldo Cruz. 2020;115:e190383.
• ⁴
  Silva PCV, Gomes AV, de Britto LRPB, Lima ELS, da Silva JL, Montenegro SML, et al. Influence of a TNF-a Polymorphism on the Severity of Schistosomiasis Periportal Fibrosis in the Northeast of Brazil. Genet Test Mol Biomarkers. 2017;21(11):658-62.
• ⁵
  Coelho FF, Perini MV, Kruger JAP, Fonseca GM, Araújo RLC, Makdissi FF, et al. Management of variceal hemorrhage: current concepts. Arq Bras Cir Dig. 2014;27(02):138-44.
• ⁶
  Saha P, Smith A. TNF-α (Tumor Necrosis Factor-α) A Paradox in Thrombosis. Arterioscler Thromb Vasc Biol. 2018;38(11):2542-3.
• ⁷
  Richter J, Domingues ALC, Barata CH, Prata AR, Lambertucci JR. Report of the second satellite symposium on ultrasound in schistosomiasis. Mem Inst Oswaldo Cruz . 2001; 96:151-6.
• ⁸
  Gunda DW, Kilonzo SB, Manyiri PM, Peck RN, Mazigo HD. Morbidity and mortality due to Schistosoma mansoni related periportal fibrosis: could early diagnosis of varices improve the outcome following available treatment modalities in Sub Saharan Africa? A scoping review. Trop Med Infect Dis. 2020;5(1):20. Available from: https://doi.org/10.3390/tropicalmed5010020 PMID: 32028581
  » https://doi.org/10.3390/tropicalmed5010020 PMID: 32028581
• ⁹
  Opio CK, Kazibwe F, Ocama P, Rejani L, Belousova EN, Ajal P. Profiling lifetime episodes of upper gastrointestinal bleeding among patients from rural Sub-Saharan Africa where Schistosoma mansoni is endemic. Pan Afr Med J. 2016;24(296):1-9.
• ¹⁰
  Moukoko CE, Wali NE, Saeed OK, Mohamed-Ali Q, Gaudart J, Dessein AJ, et al. No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection. Infect Immun. 2003;71(10):5456-60.
• ¹¹
  Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, et al. Interleukin-10 or tumor necrosis factor-a polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine. 2006;34(1-2):24-31.
• ¹²
  Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997;94(07):3195-9.
• ¹³
  Franco KGS, Amorim FJR, Santos MA, Rollemberg CVV, de Oliveira FA, França AVC, et al. Association of IL-9, IL-10, and IL-17 Cytokines with Hepatic Fibrosis in Human Schistosoma mansoni Infection. Front Immunol. 2021;12:779534.
• ¹⁴
  Baltieri L, Chaim EA, Chaim FDM, Utrini MP, Gestic MA, Cazzo E. Correlation between nonalcoholic fatty liver disease features and levels of adipokines and inflammatory cytokines among morbidly obese individuals. Arq Gastroenterol, 2018;55(3):247-51.
• ¹⁵
  Dong Y, Liu Y, Kou1 X, Jing Y, Sun K, Sheng D, et al. The protective or damaging effect of Tumor necrosis factor-α in acute liver injury is concentration-dependent. Cell Biosci, 2016;6:8.

• Financial Support: The Universidade Federal de Pernambuco (UFPE), Brazil, provided financial support for molecular biology experiments and dosages of serum TNF-α and IL-10. Supported by Pró-Reitoria para Assuntos de Pesquisa e Pós-Graduação (PROPESQ) (23076. 019166.2012/63).

Publication Dates

• Publication in this collection
  20 Feb 2023
• Date of issue
  2023

History

• Received
  28 Nov 2021
• Accepted
  22 Aug 2022